Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc.（LFCR）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · LFCR · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
10
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Lifecore Biomedical, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
LFCR 季度内部人买卖趋势
LFCR 内幕交易卖出 · LFCR 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · LFCR CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
LFCR 高管卖出股份 · LFCR 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 4, 2026 | Kiper Christopher S Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | OBUS NELSON Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | Aryeh Jason Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | Schechter Joshua Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | Korenberg Matthew E Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | Antunes Humberto Calheiros Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | Johnson Paul Harold Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | HOUDE LOVAS KATRINA Director | Award | 25,907 | — | Form 4 |
| May 20, 2026 | Josephs Paul CEO · Director | Other | 40,413 | $185K | Form 4 |
| Apr 14, 2026 | Salus Thomas D. Chief Legal & Administration | Other | 24,645 | $128K | Form 4 |
| Mar 2, 2026 | Salus Thomas D. Chief Legal & Administration | Award | 30,000 | — | Form 4 |
| Sep 3, 2025 | Lake Ryan David CFO | Other | 22,932 | $177K | Form 4 |
| Jul 15, 2025 | OBUS NELSON Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Kiper Christopher S Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Johnson Paul Harold Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Aryeh Jason Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Korenberg Matthew E Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Antunes Humberto Calheiros Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Schechter Joshua Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | HOUDE LOVAS KATRINA Director | Award | 19,506 | — | Form 4 |
| Jul 8, 2025 | Salus Thomas D. Chief Legal & Administration | Option | 37,000 | — | Form 4 |
| Jul 8, 2025 | Salus Thomas D. Chief Legal & Administration | Other | 11,022 | $90K | Form 4 |
| Jul 8, 2025 | Lake Ryan David CFO | Option | 75,000 | — | Form 4 |
| Jul 8, 2025 | Lake Ryan David CFO | Other | 32,806 | $269K | Form 4 |
| Jul 8, 2025 | Josephs Paul CEO · Director | Option | 150,000 | — | Form 4 |
Salus Thomas D.
Chief Legal & Administration
日期
Apr 14
股数
24,645
均价
$5.20
总金额
$128K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 LFCR 内幕交易
LFCR 内幕交易
Lifecore Biomedical, Inc.（LFCR）内幕交易数据来源于公司内部人（包括Salus Thomas D. (Chief Legal & Administration), Josephs Paul (CEO · Director), Lake Ryan David (CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。LFCR内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Lifecore Biomedical, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
LFCR 内幕交易 · 5个问题Lifecore Biomedical, Inc.（LFCR）的内部人包括高管和董事，如Salus Thomas D. (Chief Legal & Administration), Josephs Paul (CEO · Director), Lake Ryan David (CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026